| Dr F Bruce Coles, DO | |
|
13 S Helderberg Pkwy, Slingerlands, NY 12159-9703 | |
| (518) 439-3922 | |
| Not Available |
| Full Name | Dr F Bruce Coles |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 13 S Helderberg Pkwy, Slingerlands, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538467139 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 180696-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr F Bruce Coles, DO 13 S Helderberg Pkwy, Slingerlands, NY 12159-9703 Ph: (518) 439-3922 | Dr F Bruce Coles, DO 13 S Helderberg Pkwy, Slingerlands, NY 12159-9703 Ph: (518) 439-3922 |
News Archive
Evergreen Life, the App that allows people to manage their health and wellness by placing their personal health record at their fingertips, has surpassed 250,000 users.
Vitamin D deficiency was an indicator of aggressive prostate cancer and spread of the disease in European-American and African-American men who underwent their first prostate biopsy because of abnormal prostate-specific antigen (PSA) and/or digital rectal examination (DRE) test results, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
In response to the alarming increase in the overweight and obese population in Kansas, a representative of the American Society of Bariatric Physicians (ASBP) recently testified to the Kansas State Board of Healing Arts. ASBP is America's oldest and most experienced society devoted to the medical treatment of overweight and obesity and associated health conditions and risks.
Celgene today announced that data from the FIRST (Frontline Investigation of lenalidomide and dexamethasone vs. standard thalidomide) trial was presented on Sunday 8 December, during the Plenary Scientific Session at the 55th American Society Hematology annual meeting in New Orleans. FIRST (MM-020/IFM 07-01) a phase III, multi-centre study in patients newly diagnosed with multiple myeloma and ineligible for stem cell transplant, included 72 patients from the UK.
› Verified 3 days ago
Debra Carol Zimring, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 New Scotland Rd Ste 203, Slingerlands, NY 12159 Phone: 518-439-2460 Fax: 518-439-3025 | |
Steven L. Bratman, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 34 Olympian Dr, Slingerlands, NY 12159 Phone: 970-218-9879 |